More than 30 U.S. senators, including U.S. Sen. Kirsten Gillibrand of New York, have sent a letter requesting answers from a pharmaceutical company that reportedly raised the price of its opioid overdose reversal medication by nearly $4,000.

According to multiple press reports, Kaleo Pharmaceuticals increased the price of the drug, Evzio, from $690 for a two-pack in 2014 to $4,500 today. The senators are concerned that communities and families won’t be able to access the drug at a time when heroin and opioid addiction has become an epidemic.

In their letter to Kaleo Pharmaceuticals CEO Spencer Williamson, the senators said the price hike is “very concerning.”

Read More

Related Articles